loader2
Partner With Us NRI

Aster DM Healthcare Ltd share Price Today

Company details

361.20
367.25
256.35
558.00
6M Return 8.27%
1Y Return 40.51%
Mkt Cap.(Cr) 18,277.18
Volume 1,014,393
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 1,014,393

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Numbers driven by strong GCC performance…
About The Stock

    Aster operates a network of hospitals, clinics, retail pharmacies in several GCC countries as well as India.

    • Its network consists of 15 hospitals, 113 clinics and 257 retail pharmacies in GCC states;15 hospitals, 12 clinics and 177 labs in India; total bed capacity: GCC: 1441, India: 4095
    • Revenue break-up Q3FY23: hospitals: 55%, pharmacies: 25%, clinics: 20% with GCC & India contributing 78% & 22% of revenues, respectively
Q3FY23

    Strong numbers propelled by GCC.

    • Revenues grew 13.3% QoQ to ₹ 3192 crore driven by 17.3% QoQ growth in the GCC business to ₹ 2550 crore. India was steady with 1.7% QoQ growth to ₹ 735 crore
    • EBITDA margins improved 273 bps QoQ to 14.1% while EBITDA grew 40.7% QoQ to ₹ 449 crore
    • Subsequently, net profit increased 201.6% QoQ to ₹ 139 crore

Click here for full recommendation

Research view on more stocks

Healthcare facilities company Aster DM Healthcare announced Q3FY24 & 9MFY24 results:

Financial Highlights for Q3FY24:

  • Operational revenue grew 16% YoY to Rs 3,711 crore Vs. Rs 3,192 crore in Q3FY23.
  • Operating EBITDA grew 28% YoY to Rs 583 crore Vs. Rs. 456 crore in Q3FY23.
  • PAT (excluding losses from new hospital and non-recurring costs) grew 53% YoY to Rs 213 crore Vs. 139 crore in Q3FY23.

Financial Highlights for 9MFY23:

  • Operational revenue grew 18% YoY to Rs 10,243 crore Vs. Rs 8,671 crore in 9MFY23.
  • Operating EBITDA grew 28% YoY to Rs 1,375 crore Vs. Rs 1,076 crore in 9MFY23.
  • PAT (excluding losses from new hospitals and non-recurring costs) grew 45% YoY to Rs 335 crore Vs. Rs 231 crore in 9MFY23.

Commenting on the results, Dr. Azad Moopen, Founder, Chairman and Managing Director, Aster DM Healthcare, said, “We extend our heartfelt gratitude to our shareholders for their resounding endorsement of our decision to segregate our GCC operations. This overwhelming support fuels our drive to enhance and expand our operations in India, reaffirming our commitment to the trust they have placed in our strategic vision. 

In Q3FY24, our India business showcased 23% YoY revenue growth, surging to Rs 949 crore This growth was catalyzed by the expansion of over 750 beds within the past year. Through diligent cost optimization initiatives and leveraging operational efficiencies, we achieved 37% YoY increase in Operating EBITDA in Q3FY24, elevating our hospitals' Operating EBITDA margins to 19.8% and contributing to more than doubling the Net Profit after taxes for the quarter.

I am also glad to mention that our flagship Aster Medcity hospital has been recognized as the No.1 'Best Multi-specialty Hospital Emerging' by The Week-Hansa Research 2023, a testament to our unwavering commitment towards excellence.

As we continue our journey, we remain steadfast in our pursuit of growth, with plans to increase our capacity beds to 6,600, showcasing our dedication towards further strengthening our strong position among India's leading healthcare providers."

 

 

Result PDF

View Other Company Results

Aster DM Healthcare Ltd shares SWOT Analysis

Strengths (3)

  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Increasing Revenue every quarter for the past 2 quarters
  • High dividends, with rising dividend yields over last five years

Weakness (4)

  • Declining Net Cash Flow : Companies not able to generate net cash
  • Companies with High Promoter Pledge
  • Major fall in TTM Net Profit

Opportunity (1)

  • Turnaround companies- loss to profit QoQ

Threats (1)

  • High PE (PE > 40)

Resistance and support

R1 368.4
R2 370.8
R3 374.4
Pivot

364.78

S1 362.3
S2 358.7
S3 356.3
EMA SMA
366.2
394.0
401.4
380.0
350.4
407.6
422.9
383.5
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
NIPPON INDIA MUTUAL FUND Bulk Purchase 2024-03-27 405 10342074 BSE
SBI MUTUAL FUND Bulk Purchase 2024-03-27 405 7691435 BSE
ICICI PRUDENTIAL MUTUAL FUND Bulk Purchase 2024-03-27 405 5432104 BSE
Name Category Shares
Union Investments Private Limited PROMOTER 37.41%
Union (Mauritius) Holdings Limited PROMOTER 4%

OUR RESEARCH VIEW

Investment recommendation
Numbers driven by strong GCC performance…
Call Date
15 Feb 2023
Entry Price 210.00
Target Price 280.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Aster DM Healthcare Ltd Stocks COMPARISON

Financials( in Cr) Aster DM Healthcare Ltd Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Fortis Healthcare Ltd Global Health Ltd
Price 365.90 5,914.35 789.40 462.00 1,184.45
% Change 0.84 -0.93 -1.70 -1.48 -1.44
Mcap Cr 18,277.18 85,039.48 76,722.73 34,879.06 31,803.31
Revenue TTM Cr 11,932.88 16,612.50 4,831.37 6,537.06 2,694.25
Net Profit TTM Cr 475.49 887.50 1,103.51 632.98 326.08
PE TTM 52.40 108.28 72.57 59.43 66.45
1 Year Return 40.51 29.97 42.56 59.86 104.80
ROCE 9.22 14.16 13.85 7.51 16.49
ROE 12.43 15.04 16.12 6.79 16.13
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 4,448.07 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 33,796.39 -24,413.80
LAST 3M 102,786.44 -26,675.26
LAST 6M 169,824.52 52,410.32
LAST 12M 262,867.28 126,756.31
Aster DM Healthcare Limited - Analysts/Institutional Investor Meet/Con. Call Updates

May 24, 2024 l NSE Announcement

Aster DM Healthcare Limited - Board Meeting

May 23, 2024 l NSE Announcement

Date Action Type Ratio
Apr 23, 2024 Dividend 1180

Aster DM Healthcare Ltd Information

Stock PE (TTM)
52.4
Promoter Holding
41.88%
Book Value
87.5457
ROCE
9.22%
ROE
12.43%
Description
  • Aster DM Healthcare Ltd. is an Indian conglomerate healthcare provider. It operates medical centres, diagnostic centres, laboratories, hospitals, and pharmacies in the Middle East and India. The company was incorporated in 1987 with headquarters in Dubai, UAE. During FY 2021-2022, Aster DM Healthcare Ltd. Reported a total revenue of Rs 10,303.94 crore, up 19.01% against Rs 8,658.40 crore recorded in the previous financial year, 2020-2021. On 14 October 2022, the company’s market capitalisation stood at Rs 12,080 crore.

    The company is listed on the Bombay Stock Exchange with the code 540975, and on the National Stock Exchange with the code ASTERDM.

    Aster DM Healthcare Ltd. provides services in areas like dental, diabetology, general medicine, cardiology, dermatology, endocrinology, dietetics, ENT, general surgery, neurology, orthopaedics, psychiatry, gynaecology, gastroenterology, ophthalmology, paediatrics, pulmonology, and urology. The company was formerly called Dr Moopen Group and changed its name to DM Healthcare Ltd. in 2008.

    On 30 June 2022, the company’s shareholding pattern showed a 37.88% promoter stake, 11.44% foreign institutional investor stake, 9.65% domestic institutional investor stake, and 40.57% public stake. Union Investments Pvt Ltd. is the leading promoter with a 37.41% stake. In the June 2022 quarter, the promoters’ pledge remained unchanged at 10.44% of the holdings, while mutual fund holdings increased from 8.12% to 9.62%.

    The founder of Aster DM Healthcare Ltd. is Mr Azad Moopen. The company’s leadership team comprises Ms Fara Siddiqui, Dr Malathi Arshanapalai, Mr Veneeth Purushotaman, Dr Shanila Laiju, Mr Brandon Rowberry, Mr N S Balasubramanian, Mr T J Wilson, Ms Alisha Moopen, and Mr Sreenath P Reddy. Its auditors are Deloitte Haskins & Sells. As of 30 June 2022, the company had a total of 49.95 crore shares outstanding.

    On 14 October 2022, the company’s share price closed at Rs 241.90 on BSE. It closed at Rs 241.85 on NSE. Aster DM Healthcare Ltd.’s 52-week high share price was Rs 265.55, and the 52-week low share price was Rs 158.

    The company’s peers include Apollo Hospitals Enterprises Ltd., Max Healthcare Institute Ltd., Fortis Healthcare Ltd., and Dr Lal PathLabs Ltd.

    As of September 2022, HDFC Small Cap Fund had a 3.01% stake in the company. SBI Contra Fund, ICICI Prudential Smallcap Fund, and HDFC Children’s Gift Fund had 2.19%, 1.83%, and 1.49% stakes, respectively.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose

Registered Address

IX/475L Aster Medcity, Kuttisahib Road Cheranalloore, Kochi, Kerala, 682027

Tel : 91-0484-6699228
Email : cs:asterdmhealthcare.com
Website : http://www.asterdmhealthcare.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 540975
NSE Code : ASTERDM
Book Closure Date (Month) :
BSE Group : A
ISIN : INE914M01019

FAQ’s on Aster DM Healthcare Ltd Shares

You can buy Aster DM Healthcare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aster DM Healthcare Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 24, 2024 03:59 PM the closing price of Aster DM Healthcare Ltd was Rs.365.90.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 24, 2024 03:59 PM, the market cap of Aster DM Healthcare Ltd stood at Rs. 18,277.18.

The latest PE ratio of Aster DM Healthcare Ltd as of May 24, 2024 03:59 PM is 52.40

The latest PB ratio of Aster DM Healthcare Ltd as of May 24, 2024 03:59 PM is 0.24

The 52-week high of Aster DM Healthcare Ltd share price is Rs. 558.00 while the 52-week low is Rs. 256.35

According to analyst recommendations, Aster DM Healthcare Ltd Share has a "Buy" rating for the long term.

Download App

Download Our App

Play Store App Store
market app